Literature DB >> 31741995

Masses of the Paranasal Sinuses After Treatment of Nasopharyngeal Carcinoma: A Case Report.

Maria Silvia Lazio1, Angelo Cannavicci1, Massimo Squadrelli Saraceno1, Giandomenico Maggiore1.   

Abstract

The development of a new mass in the field of irradiation of a previously treated Nasopharyngeal carcinoma is generally considered a sign of recurrence. We report a case of a 46-year-old male, with a past history of undifferentiated NPC, with an expansive lesion discovered during radiological follow-up that occupied nasal cavity and paranasal sinuses. The endoscopic sinuses surgery was necessary in order to analyze and remove the mass with intraoperative frozen sections to highlight mucosa free from disease. The presence of non-malignant masses in the paranasal sinuses are rare complications after radiotherapy at the skull base, but represent an eventuality that must be considered in the differential diagnosis of a suspected recurrence or with a secondary malignancies after radiation therapy. It is therefore required a final diagnosis based on biopsy, follow-up and an eventual endoscopic surgical treatment. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Bone erosion; Endoscopic sinus surgery; Nasal masses; Nasopharyngeal carcinoma; Paranasal sinuses

Year:  2018        PMID: 31741995      PMCID: PMC6848647          DOI: 10.1007/s12070-018-1326-3

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  9 in total

1.  Endoscopic management of skull base osteoradionecrosis.

Authors:  K P Chang; N M Tsang; C Y Chen; J L Su; S P Hao
Journal:  Laryngoscope       Date:  2000-07       Impact factor: 3.325

2.  Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A T C Chan; V Grégoire; J-L Lefebvre; L Licitra; E P Hui; S F Leung; E Felip
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

3.  Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.

Authors:  Shyh-An Yeh; Yeh Tang; Chun-Chung Lui; Yu-Jie Huang; Eng-Yen Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

4.  Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.

Authors:  Wei-Wei Xiao; Shao-Min Huang; Fei Han; Shao-Xiong Wu; Li-Xia Lu; Cheng-Guang Lin; Xiao-Wu Deng; Tai-Xiang Lu; Nian-Ji Cui; Chong Zhao
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

5.  Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.

Authors:  Jingfeng Zong; Shaojun Lin; Jin Lin; Linbo Tang; Bijuan Chen; Mingwei Zhang; Yu Zhang; Luying Xu; Yunbin Chen; Youping Xiao; Yanhong Fang; Jianji Pan
Journal:  Oral Oncol       Date:  2014-11-06       Impact factor: 5.337

6.  MR imaging of nonmalignant polyps and masses of the nasopharynx and sphenoid sinus after radiotherapy for nasopharyngeal carcinoma.

Authors:  A D King; A T Ahuja; S-F Leung; J Abrigo; J K T Wong; W S Poon; K S Woo; H S Chan; G M K Tse
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-08       Impact factor: 3.825

7.  Sinus mucosa status in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A 5-year follow-up.

Authors:  Chung-Han Hsin; Hsien-Chun Tseng; Huang-Pin Lin; Tsai-Hsin Chen
Journal:  Head Neck       Date:  2015-04-06       Impact factor: 3.147

Review 8.  Prevention and treatment of the consequences of head and neck radiotherapy.

Authors:  A Vissink; F R Burlage; F K L Spijkervet; J Jansma; R P Coppes
Journal:  Crit Rev Oral Biol Med       Date:  2003

Review 9.  Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.

Authors:  Crispian Scully; Joel Epstein; Stephen Sonis
Journal:  Head Neck       Date:  2003-12       Impact factor: 3.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.